PRTK - パラテック・ファ―マシュ―ティカルズ (Paratek Pharmaceuticals Inc. )

PRTKのニュース

   The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs  2021/02/10 12:34:42 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 10) 9 Meters Biopharma Inc (NASDAQ: NMTR ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) AngioDynamics, Inc. (NASDAQ: ANGO ) argenx SE – ADR (NASDAQ: ARGX ) Arcus Biosciences Inc (NYSE: RCUS ) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) Assertio Holdings Inc (NASDAQ: ASRT ) Bausch Health Companies Inc (NYSE: BHC ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Celcuity Inc (NASDAQ: CELC ) Cellular Biomedicine Group Inc (NASDAQ: CBMG ) ChemoCentryx Inc (NASDAQ: CCXI ) Chimerix Inc (NASDAQ: CMRX ) Clearpoint Neuro Inc (NASDAQ: CLPT ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) DarioHealth Corp (NASDAQ: DRIO ) Edap Tms SA (NASDAQ: EDAP ) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Evogene Ltd (NASDAQ: EVGN ) Eyenovia Inc (NASDAQ: EYEN ) Glaukos Corp (NYSE: GKOS ) Guardion Health Sciences Inc (NASDAQ: GHSI ) Haemonetics Corporation (NYSE: HAE ) Fulgent Genetics Inc (NASDAQ: FLGT ) Halozyme Therapeutics, Inc.
   Paratek Pharmaceuticals Receives $60 Million Non-Recourse Loan from R-Bridge Healthcare Investment Advisory, Ltd., an affiliate of CBC Group  2021/01/04 22:00:00 GlobeNewswire
Proceeds Used to Prepay Outstanding Loan with Hercules Capital, Inc.
   Insider Selling: Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Chairman Sells $127,442.15 in Stock  2020/12/18 14:04:41 Watchlist News
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Chairman Michael Bigham sold 18,337 shares of the company’s stock in a transaction on Friday, December 11th. The shares were sold at an average price of $6.95, for a total transaction of $127,442.15. Following the transaction, the chairman now owns 572,580 shares of the company’s stock, valued at $3,979,431. The transaction […]
   Insider Selling: Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Chairman Sells $174,882.73 in Stock  2020/12/18 12:14:41 Watchlist News
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Chairman Michael Bigham sold 26,063 shares of Paratek Pharmaceuticals stock in a transaction that occurred on Monday, December 14th. The shares were sold at an average price of $6.71, for a total transaction of $174,882.73. Following the sale, the chairman now directly owns 572,580 shares in the company, valued at approximately […]
   William M. Haskel Sells 4,814 Shares of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Stock  2020/12/16 12:38:41 Watchlist News
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) General Counsel William M. Haskel sold 4,814 shares of the business’s stock in a transaction dated Friday, December 11th. The stock was sold at an average price of $6.95, for a total transaction of $33,457.30. Following the sale, the general counsel now owns 210,109 shares in the company, valued at $1,460,257.55. […]
   The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs  2021/02/10 12:34:42 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 10) 9 Meters Biopharma Inc (NASDAQ: NMTR ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) AngioDynamics, Inc. (NASDAQ: ANGO ) argenx SE – ADR (NASDAQ: ARGX ) Arcus Biosciences Inc (NYSE: RCUS ) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) Assertio Holdings Inc (NASDAQ: ASRT ) Bausch Health Companies Inc (NYSE: BHC ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Celcuity Inc (NASDAQ: CELC ) Cellular Biomedicine Group Inc (NASDAQ: CBMG ) ChemoCentryx Inc (NASDAQ: CCXI ) Chimerix Inc (NASDAQ: CMRX ) Clearpoint Neuro Inc (NASDAQ: CLPT ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) DarioHealth Corp (NASDAQ: DRIO ) Edap Tms SA (NASDAQ: EDAP ) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Evogene Ltd (NASDAQ: EVGN ) Eyenovia Inc (NASDAQ: EYEN ) Glaukos Corp (NYSE: GKOS ) Guardion Health Sciences Inc (NASDAQ: GHSI ) Haemonetics Corporation (NYSE: HAE ) Fulgent Genetics Inc (NASDAQ: FLGT ) Halozyme Therapeutics, Inc.
   Paratek Pharmaceuticals Receives $60 Million Non-Recourse Loan from R-Bridge Healthcare Investment Advisory, Ltd., an affiliate of CBC Group  2021/01/04 22:00:00 GlobeNewswire
Proceeds Used to Prepay Outstanding Loan with Hercules Capital, Inc.
   Insider Selling: Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Chairman Sells $127,442.15 in Stock  2020/12/18 14:04:41 Watchlist News
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Chairman Michael Bigham sold 18,337 shares of the company’s stock in a transaction on Friday, December 11th. The shares were sold at an average price of $6.95, for a total transaction of $127,442.15. Following the transaction, the chairman now owns 572,580 shares of the company’s stock, valued at $3,979,431. The transaction […]
   Insider Selling: Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Chairman Sells $174,882.73 in Stock  2020/12/18 12:14:41 Watchlist News
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Chairman Michael Bigham sold 26,063 shares of Paratek Pharmaceuticals stock in a transaction that occurred on Monday, December 14th. The shares were sold at an average price of $6.71, for a total transaction of $174,882.73. Following the sale, the chairman now directly owns 572,580 shares in the company, valued at approximately […]
   William M. Haskel Sells 4,814 Shares of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Stock  2020/12/16 12:38:41 Watchlist News
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) General Counsel William M. Haskel sold 4,814 shares of the business’s stock in a transaction dated Friday, December 11th. The stock was sold at an average price of $6.95, for a total transaction of $33,457.30. Following the sale, the general counsel now owns 210,109 shares in the company, valued at $1,460,257.55. […]
   The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs  2021/02/10 12:34:42 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 10) 9 Meters Biopharma Inc (NASDAQ: NMTR ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) AngioDynamics, Inc. (NASDAQ: ANGO ) argenx SE – ADR (NASDAQ: ARGX ) Arcus Biosciences Inc (NYSE: RCUS ) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) Assertio Holdings Inc (NASDAQ: ASRT ) Bausch Health Companies Inc (NYSE: BHC ) BridgeBio Pharma Inc (NASDAQ: BBIO ) Celcuity Inc (NASDAQ: CELC ) Cellular Biomedicine Group Inc (NASDAQ: CBMG ) ChemoCentryx Inc (NASDAQ: CCXI ) Chimerix Inc (NASDAQ: CMRX ) Clearpoint Neuro Inc (NASDAQ: CLPT ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) DarioHealth Corp (NASDAQ: DRIO ) Edap Tms SA (NASDAQ: EDAP ) Eton Pharmaceuticals Inc (NASDAQ: ETON ) Evogene Ltd (NASDAQ: EVGN ) Eyenovia Inc (NASDAQ: EYEN ) Glaukos Corp (NYSE: GKOS ) Guardion Health Sciences Inc (NASDAQ: GHSI ) Haemonetics Corporation (NYSE: HAE ) Fulgent Genetics Inc (NASDAQ: FLGT ) Halozyme Therapeutics, Inc.
   Paratek Pharmaceuticals Receives $60 Million Non-Recourse Loan from R-Bridge Healthcare Investment Advisory, Ltd., an affiliate of CBC Group  2021/01/04 22:00:00 GlobeNewswire
Proceeds Used to Prepay Outstanding Loan with Hercules Capital, Inc.
   Insider Selling: Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Chairman Sells $127,442.15 in Stock  2020/12/18 14:04:41 Watchlist News
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Chairman Michael Bigham sold 18,337 shares of the company’s stock in a transaction on Friday, December 11th. The shares were sold at an average price of $6.95, for a total transaction of $127,442.15. Following the transaction, the chairman now owns 572,580 shares of the company’s stock, valued at $3,979,431. The transaction […]
   Insider Selling: Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Chairman Sells $174,882.73 in Stock  2020/12/18 12:14:41 Watchlist News
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Chairman Michael Bigham sold 26,063 shares of Paratek Pharmaceuticals stock in a transaction that occurred on Monday, December 14th. The shares were sold at an average price of $6.71, for a total transaction of $174,882.73. Following the sale, the chairman now directly owns 572,580 shares in the company, valued at approximately […]
   William M. Haskel Sells 4,814 Shares of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Stock  2020/12/16 12:38:41 Watchlist News
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) General Counsel William M. Haskel sold 4,814 shares of the business’s stock in a transaction dated Friday, December 11th. The stock was sold at an average price of $6.95, for a total transaction of $33,457.30. Following the sale, the general counsel now owns 210,109 shares in the company, valued at $1,460,257.55. […]

calendar